Deciphering the Effects of Semaglutide Across the Glycemic Spectrum

Shivani Misra^{1

2}

Affiliations

¹ Division of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
² Department of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, U.K.

Editorial

Shivani Misra. Diabetes Care. 2024.

. 2024 Aug 1;47(8):1322-1324.

doi: 10.2337/dci24-0057.

Shivani Misra^{1

2}

¹ Division of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
² Department of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, U.K.

No abstract available

Comment on

Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.
Kahn SE, Deanfield JE, Jeppesen OK, Emerson SS, Boesgaard TW, Colhoun HM, Kushner RF, Lingvay I, Burguera B, Gajos G, Horn DB, Hramiak IM, Jastreboff AM, Kokkinos A, Maeng M, Matos ALSA, Tinahones FJ, Lincoff AM, Ryan DH; SELECT Trial Investigators. Kahn SE, et al. Diabetes Care. 2024 Aug 1;47(8):1350-1359. doi: 10.2337/dc24-0491. Diabetes Care. 2024. PMID: 38907683 Free PMC article. Clinical Trial.
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.
Lingvay I, Deanfield J, Kahn SE, Weeke PE, Toplak H, Scirica BM, Rydén L, Rathor N, Plutzky J, Morales C, Lincoff AM, Lehrke M, Jeppesen OK, Gajos G, Colhoun HM, Cariou B, Ryan D; SELECT Trial Investigators. Lingvay I, et al. Diabetes Care. 2024 Aug 1;47(8):1360-1369. doi: 10.2337/dc24-0764. Diabetes Care. 2024. PMID: 38907684 Free PMC article. Clinical Trial.